As of 2024-12-14, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (25.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -1258.2%.
The range of the Relative Valuation is (16.22) - (25.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 23.7x | 22.3x |
| Forward P/E multiples | 14.8x - 25.3x | 24.9x |
| Fair Price | (16.22) - (25.89) | (25.83) |
| Upside | -827.3% - -1261.2% | -1258.2% |
| Date | P/E |